StonvexLoading…
StonvexStonvexStonvexCore line items from LLY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $65.18B | $45.04B | $34.12B | $28.54B |
Operating Income | $25.73B | $12.68B | $6.55B | $6.81B |
Net Income | $20.64B | $10.59B | $5.24B | $6.24B |
EPS (Diluted) | $22.95 | $11.71 | $5.80 | $6.90 |
Total Assets | $112.48B | $78.72B | $64.01B | $49.49B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $7.27B | $3.27B | $2.82B | $2.07B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 899.30M | 904.10M | 903.30M | 904.62M |